2Xideas AG Sells 62,256 Shares of Halozyme Therapeutics, Inc. $HALO
2Xideas AG reduced its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 25.2% during the second quarter, according to its most recent filing with the SEC. The fund owned 184,546...